-
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trialLopes RD, Vora AN, Liaw D et al. -
Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent ImplantationS Kubo, A Kuwayama, T Shimada et al.
-
Utility and Challenges of an Early Invasive Strategy in Patients Resuscitated From Out-of-Hospital Cardiac ArrestJC Jentzer, J Herrmann, A Prasad et al.
-
Homeostatic Chemokines and Prognosis in Patients With Acute Coronary SyndromesKC, M Hartford, A Ravn-Fischer, E Lorentzen et al.
-
Systems of Care for ST-Segment–Elevation Myocardial Infarction: A Policy Statement From the American Heart AssociationAK Jacobs, MJ Ali, , and on behalf of the American Heart Association Advocacy Coordinating Committee
-
Prevalence of Angina Among Primary Care Patients With Coronary Artery DiseaseDM Blumenthal, SE Howard, JS Como et al.
-
Switching P2Y12-receptor inhibitors in patients with coronary artery diseaseRollini F, Franchi F, Angiolillo DJ.
-
Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance SubstudyKyhl K, Ahtarovski KA, Nepper-Christensen L et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
